Gene study aims to personalize prediabetes treatment

NCT ID NCT05119179

First seen Mar 18, 2026 · Last updated Apr 29, 2026 · Updated 7 times

Summary

This study looks at how genes influence the body's response to a natural hormone called GLP-1 in Mexican-Americans with prediabetes. Researchers will analyze DNA and gene activity to understand why some people respond differently to GLP-1, which helps lower blood sugar and weight. The goal is to find genetic markers that could guide personalized treatments for diabetes and related conditions. About 300 adults with prediabetes and obesity or metabolic risk will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PREDIABETES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UTHealth Clinical Research Unit (CRU) at UT Brownsville

    RECRUITING

    Brownsville, Texas, 78520, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.